Javelin Biotech Inc.
Billerica, MA
- UEI
- KNL3VGH5KWM5
- CAGE
- 87TB0
- Primary NAICS
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 900 Middlesex Turnpike, Billerica, MA 01821, USA
- Website
- javelinbiotech.com
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 87 Engineering & Management Services
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
About Javelin Biotech Inc.
Javelin Biotech Inc., a for-profit biotech firm headquartered in Billerica, Massachusetts, is a federal grant recipient specializing in human microphysiological systems (tissue chips) for drug metabolism, pharmacokinetics, and toxicity testing, operating exclusively as a prime recipient under the National Institutes of Health.
Javelin's federal grant portfolio centers on developing and validating integrated liver-tissue-chip platforms to replace animal models in pharmaceutical preclinical testing. The National Center for Advancing Translational Sciences (NCATS, CFDA 93.350) and the National Institute of General Medical Sciences (NIGMS) fund all five of Javelin's recent federal awards. Most recent work includes a $349,677 NCATS Project Grant awarded July 1, 2026 (completion December 31, 2026) investigating the impact of metabolic disease states on pharmacodynamics and toxicity of FDA-approved antisense oligonucleotide drugs using Javelin's Liver Tissue Chip Plus platform integrated with kidney tissue models. An earlier $349,677 NCATS Project Grant awarded August 30, 2023 (completion July 31, 2025) focused on hepatic clearance prediction for drug metabolism and pharmacokinetic testing using a human liver tissue chip and translational software, addressing the pharmaceutical industry's need for faster, cheaper, and more human-relevant alternatives to animal-based testing. A third NCATS award from August 2022 (completion May 31, 2024) supported development of an interconnected liver-adipose tissue chip for testing drug combinations targeting metabolic-associated fatty liver disease. An NIGMS Project Grant from September 2021 addressed drug-drug interaction testing on optimized liver microphysiological systems.
Customer concentration is singular: the National Institutes of Health accounts for 100% of awards, with NCATS funding four grants and NIGMS funding one. Combined obligated federal dollars across all five awards total $6.6 million. One award reaches ultimate completion within the next twenty-four months. Javelin operates exclusively as a prime grant recipient with no subcontract footprint in the federal space.
Quick answers
What is Javelin Biotech Inc.'s UEI?
Javelin Biotech Inc.'s Unique Entity ID (UEI) in SAM.gov is KNL3VGH5KWM5.
What is Javelin Biotech Inc.'s CAGE code?
Javelin Biotech Inc.'s CAGE code is 87TB0.
What is Javelin Biotech Inc.'s primary NAICS code?
Javelin Biotech Inc.'s primary NAICS code is 541715 (Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)).
Where is Javelin Biotech Inc. located?
Javelin Biotech Inc.'s physical address in SAM.gov is 900 Middlesex Turnpike, Billerica, MA 01821, USA.
Is Javelin Biotech Inc. registered in SAM.gov?
Yes. Javelin Biotech Inc.'s SAM.gov registration is active through January 16, 2027.
What is Javelin Biotech Inc.'s most recent federal award?
Javelin Biotech Inc.'s most recent federal grant award is Investigating the impact of metabolic disease states on the pharmacodynamics and toxicity of FDA-approved antisense… (R43TR005374), from National Center for Advancing Translational Sciences, on July 1, 2026.
On GovTribe
See Javelin Biotech Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors